Adare Pharma Solutions to Expand Oral Dose Packaging and Warehousing Capabilities in Europe
Adare Pharma Solutions, the global CDMO specializing in oral dosage forms, announced it will enhance its facility in Milan, Italy. The expansion includes a new two-story 2,800 square-meter area housing a state-of-the-art packaging line and additional warehousing, meaning the site will be capable of handling over 50 million blisters annually, and will support tablets, capsules, and softgel packaging and cater to Adare's clients in Europe, the US, and Asia.
The facility will also see the addition of a high-shear mixer granulator to bolster oral dosage capabilities, including wet granulation processes.
These upgrades, due for completion later this year, will broaden Adare's service offerings and enhance its comprehensive CDMO solutions, underlining the company's commitment to advanced oral technologies and efficient production processes.
Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced it is further investing in its Pessano facility in Milan, Italy, with the addition of a high-shear mixer granulator to complement existing fluid bed capabilities. This addition follows the recently announced expansion of blister packaging and warehousing capabilities at the site.
To facilitate diversification of oral dosage capabilities, the Pessano facility will add an IMA 600-L Roto Mix high-shear mixer with IMILL and Hydrowash, which can provide wet granulation using either aqueous or organic-based solutions. Located within a dedicated suite, the mixer features a ‘clean in place’ design to reduce the changeover times and consumption of water and energy associated with traditional machine clean-down routines. The new granulation suite will become operational in Q3 of 2024.
“Our Pessano facility has long provided our customers with superior oral technologies, including micro and mini tablets, plain and coated tablets, and capsules,” commented Tom Sellig, CEO of Adare Pharma Solutions. “Pessano’s powerful new mixer granulator, along with the site’s expanded packaging and warehousing offerings, allows us to provide even broader capabilities and further meet the needs of our customers.”
The 20,400 square meter Pessano facility provides R&D services to expedite formulation and process development, with a seamless integrated transition to manufacturing. It is capable of manufacturing a wide range of solid dosage forms at both clinical and commercial scales, including granules, capsules, and tablets. The facility also provides controlled substance and organic solvent capabilities.
For more, please find the original story source here.
